Results 131 to 140 of about 27,986 (235)

TNFα Receptor 1 and Not Receptor 2 Affect Annulus Fibrosus and Nucleus Pulposus Response to Cytokine Challenge in a Rat Model

open access: yesJOR Spine
Background Painful intervertebral disc (IVD) degeneration (IVDD) involves chronic inflammation. Developing translational immunomodulatory strategies for IVDD is a priority with tumor necrosis factor alpha (TNFα) signaling an important target.
Timothy D. Jacobsen   +5 more
doaj   +1 more source

Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy

open access: yesBMC Veterinary Research, 2019
Background Refractory diseases, including bacterial infections, are causing huge economic losses in dairy farming. Despite efforts to prevent and treat those diseases in cattle, including the use of antimicrobials, it is not well controlled in the field.
Sotaro Fujisawa   +7 more
doaj   +1 more source

TNFa and Tnfr2 deficiencies trigger skin inflammation.

open access: yes, 2014
Zebrafish one-cell mpx:eGFP or krt18:RFP embryos were injected with standard control (Std), Tnfr2, Il1b, and/or Tnfa MOs. The expression of tnfa, il1b, and ptgs2b genes was measured by RT-qPCR in whole body (A), FACS-sorted neutrophils (B), and FACS ...
Sylwia D. Tyrkalska (560073)   +13 more
core   +1 more source

The association between TNF-receptors (TNFR1 and TNFR2) and mortality as well as kidney function decline in patients with chronic kidney disease

open access: yesUpsala Journal of Medical Sciences
Background: Higher circulating levels of tumor necrosis factor (TNF) alpha receptors 1 (TNFR1) and 2 (TNFR2) are associated with increased long-term mortality and impaired kidney function.
Per Wändell   +6 more
doaj   +1 more source

Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion [PDF]

open access: yes, 2016
Donor CD4(+)Foxp3(+) regulatory T cells (T reg cells) suppress graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (HCT [allo-HCT]). Current clinical study protocols rely on the ex vivo expansion of donor T reg cells
Ana-Laura Jordán-Garrote   +81 more
core   +1 more source

TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders

open access: yesFrontiers in Immunology, 2018
There is now compelling evidence that TNF receptor type II (TNFR2) is predominantly expressed on CD4+Foxp3+ regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), and plays a major role in the expansion and function of Tregs and MDSCs ...
Faraz Shaikh   +4 more
doaj   +1 more source

Atsttrin inhibits the binding of TL1A to DR3, similar to its inhibition of TNFa/ TNFR2 interaction.

open access: yes, 2014
ELISA plate was coated with 100(A) or TL1A (B), and then 100 ng of TNFR2 or DR3 was added to each well respectively, in the presence of various Atsttrin, the bound TNFR2 or DR3 was detected by anti-TNFR2 or anti-DR3 antibody, followed by a secondary ...
Wen Liu (39804)   +4 more
core   +1 more source

Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice.

open access: yes, 2002
Infection of susceptible mice with Plasmodium berghei Anka leads to a syndrome of severe or cerebral malaria. Tumor necrosis factor (TNF) contributes to this syndrome, apparently by acting on its receptor 2 (TNFR2) because TNFR1-/- are susceptible ...
Piguet PF, Vesin C, Kan CD
core   +1 more source

Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid‐derived suppressor cells by instigating apolarity during ageing

open access: yesMedComm
During the ageing process, TNF‐α can promote the expansion of myeloid‐derived suppressor cells (MDSCs). However, it remains unclear which receptor(s) of TNF‐α are involved in and how they modulate this process.
Ming Wang   +15 more
doaj   +1 more source

TNFR2-specific antibody fusion proteins with Fcγ receptor-independent agonism

open access: yes
Der TNFR2 gewinnt als therapeutisches Ziel zunehmend an Relevanz, da er bei einer Vielzahl von Erkrankungen, darunter bei Autoimmun- und Tumorerkrankungen, eine wichtige Rolle spielt.
Päckert, Lea
core   +1 more source

Home - About - Disclaimer - Privacy